Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ROCHE DIAGNOSTICS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2019-10-01 to 2024-09-30
Current total value of award: $1008529.39
Description: INCREASE CLIN 4002 AND 4003 PRIMARY ANTIBODIES FOR MAMC